九强生物：自然人股东ZHOU XIAOYAN计划减持公司股份不超过约221万股

Group 1 - The core point of the news is that Zhou Xiaoyan, a natural person shareholder of Jiukang Biotechnology, plans to reduce her shareholding by up to 2.21 million shares, which represents 0.38% of the company's total share capital and voting shares [1][2] - Jiukang Biotechnology's revenue composition for the year 2024 is projected to be 100% from the healthcare sector [1] Group 2 - As of the report, Jiukang Biotechnology has a market capitalization of 8.2 billion yuan [2]